ELDN - Total Utang marang Modal Eledon Pharmaceuticals, Inc
Eledon Pharmaceuticals (ELDN) is recognized as an immunology expert, developing treatments to extend recipient longevity. The company is developing innovative drugs that could replace legacy therapy protocols. Business growth relies on partnerships with transplant centers to accelerate testing. This market valuation chart on GURU.Markets shows that the debt-to-equity ratio is 0.01.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_ELDN_-_Eledon-Pharmaceuticals_-_All-Debt-to-Shareholders-Equity-Ratio "ELDN (Eledon Pharmaceuticals) riwayat Total Utang marang Modal saka 04.07.2022 nganti 31.10.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Eledon Pharmaceuticals
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Eledon Pharmaceuticals|ELDN - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Eledon Pharmaceuticals|ELDN - Gunggung utang perusahaan|Utang marang nilai buku Eledon Pharmaceuticals|ELDN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Eledon Pharmaceuticals|Likuiditas cepet eledon.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:Eledon Pharmaceuticals, Inc.
This ratio measures the proportion of borrowed funds in the financing structure relative to equity. Investors utilize this leverage to assess financial stability and bankruptcy risks. By analyzing the total debt-to-equity ratio, one can determine the company's degree of dependence on creditors. For Eledon Pharmaceuticals (ELDN), this balance is critical, as the development of tegoprubart requires significant expenditures. A high debt load could limit the capacity to implement innovative antibody therapy.
Analisis pesaing Eledon Pharmaceuticals
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|Pieris Pharmaceuticals Inc - Total Utang marang Modal|Utang marang Modal Savara Pharma|Rigel Pharmaceuticals (RIGL) - Utang marang Ekuitas|ANAB (anaptysbio.com) - Utang marang Ekuitas|ATXS (Astria Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal enGene Holdings Inc ENGN|Total Utang marang Modal RAPT|aerovatetx.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas Aclaris Therapeutics ACRS|kyvernatx.com (KYTX) - Utang marang Modal|TLSA - Utang marang Ekuitas|CABA (Cabaletta Bio Inc.) - Rasio Utang marang Ekuitas|VTYX (Ventyx Bio) - Rasio Total Utang marang Ekuitas|Theratechnologies, Inc - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Avalo Therapeutics, Inc|agenusbio.com - Utang Agregat marang Ekuitas|Total Utang marang Modal CLYM|ZURA (Zura Bio Ltd) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ATYR (aTyr)|Total Utang marang Modal Adagene Inc ADAG|IMA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STTK (Shattuck Labs, Inc.)|equilliumbio.com (EQ) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Connect Biopharma Holdings Limited|IMUX (Immunic Therapeutics) - Total Utang marang Modal|Total Utang marang Modal Atara Biotherapeutics Inc|Total Utang marang Modal IFRX|Rasio Total Utang marang Ekuitas x4pharma.com XFOR|Total Utang marang Modal ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Utang marang Modal|INMB: Rasio Total Utang marang Ekuitas|BRNS - Total Utang marang Modal|KZR (Kezar Life Sciences) - Rasio Total Utang marang Ekuitas|SABS: Utang Agregat marang Modal|AKTX (Akari Therapeutics Plc) - Total Utang marang Modal|Enlivex Therapeutics, Ltd. (ENLV) - Koefisien Total Utang marang Modal|Total Utang marang Modal QTTB|Rasio Total Utang marang Ekuitas GeoVax Corp GOVX|Total Utang marang Modal EDSA (Edesa Biotech, Inc.)|Total Utang marang Modal ibioinc.com IBIO|CARM - Utang marang Ekuitas|XTLB: Utang marang Ekuitas|boltbio.com (BOLT) - Utang marang Ekuitas|HCWB - Koefisien Total Utang marang Modal|APVO (Aptevo Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal AIM ImmunoTech, Inc. AIM|Utang marang Ekuitas Aditxt (ADTX)|Utang marang Ekuitas GRI (GRI Bio Inc)|Total Utang marang Modal XRTX (XORTX)|HIND: Rasio Utang marang Ekuitas|REVB - Utang marang Ekuitas|INDP (indaptusrx.com) - Rasio Utang marang Ekuitas|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas CALI (CalciMedica)|AFMD (Affimed NV) - Total Utang marang Modal|ALLK: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HOOK|Total Utang marang Modal igmbio.com (IGMS)|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|Rasio Kabeh Utang marang Dana Pribadi OCEA|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas